This, according to my Uro, is the next major treatment being developed with trials starting in 2 years...
Some new research:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704342/
In summary, we had shown that ADSCs could inhibit the activation of tunical albuginea MFs, reduce the expression of collagen in MFs through TGF-β1-Smad signaling pathway, suppress the contraction of myofibroblasts by RhoA-ROCK signaling pathway. In the other hand, ADSCs could degrade collagen by paracrine or promoting MFs autocrine MMPs. Furthermore, ADSCs could induce apoptosis of MFs, though the detail molecular mechanism was confusing. These findings suggested that ADSCs attenuated the development of Peyronies Disease (Fig. 7). The anti-fibrotic ability of ADSCs will be considered in future treatment approach of Peyronies Disease.
Quote from: Crooked_Stick on December 13, 2017, 01:59:32 PM
This, according to my Uro, is the next major treatment being developed with trials starting in 2 years...
Some new research:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704342/
In theory is this experimental treatment can somehow restore length or even slightly add length via remodeling of tunica?
I love the way the members have responded very well.
Nice find and thanks :)